Depletion of anti-gal antibodies in baboons by intravenous therapy with bovine serum albumin conjugated to Gal oligosaccharides

Transplantation

Volumn 73, Issue 1, 2002, Pages 129-139

  Teranishi, K ^a   Gollackner, B ^a   Buhler L ^a   Knosalla, C ^a   Correa, L ^b   Down, J D ^b   White Scharf, M E ^b   Sachs, D H ^a   Awwad, M ^b   C Cooper, D K ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BioTransplant Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; BOVINE SERUM ALBUMIN; CD40 LIGAND MONOCLONAL ANTIBODY; COBROTOXIN; CYCLOSPORIN A; EPITOPE; GALACTOSYLGALACTOSE; GALACTOSYLGALACTOSE ANTIBODY; HEMOPOIETIC GROWTH FACTOR; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MAJOR HISTOCOMPATIBILITY ANTIGEN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OLIGOSACCHARIDE; THYMOCYTE ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY AFFINITY; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; BABOON; CELL TRANSPLANTATION; CONTINUOUS INFUSION; CONTROLLED STUDY; DRUG EFFICACY; DRUG SENSITIZATION; GRAFT REJECTION; GRAFT SURVIVAL; HUMORAL IMMUNITY; IMMUNOADSORPTION; LEUKAPHERESIS; NONHUMAN; PRIORITY JOURNAL; STEM CELL; SWINE; T LYMPHOCYTE; THYMUS; TREATMENT OUTCOME; WHOLE BODY RADIATION; XENOTRANSPLANTATION;

EID: 0037080582     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200201150-00024     Document Type: Article

References (46)

1. Identification of carbohydrate structures that bind human antiporcine antibodies: Implications for discordant xenografting in humans
2. Depletion of natural antibodies in non-human primates-a step towards successful discordant xenografting in humans
3. Identification of alpha-galactosyl and other carbohydrate epitopes that are bound by human anti-pig antibodies: Relevance to discordant xenografting in man
4. Anti-pig IgM antibodies in human serum react predominantly with Gal(alpha 1-3)Gal epitopes
5. Interaction of the natural anti-Gal antibody with alpha-galactosyl epitopes: A major obstacle for xenotransplantation in humans
6. Evidence that intravenously administered alpha-galactosyl carbohydrates reduce baboon serum cytotoxicity to pig kidney cells (PK15) and transplanted pig hearts
7. In vivo immunoadsorption of antipig antibodies in baboons using a specific Gal(alpha)1-3Gal column
8. Depletion of anti-Gal(alpha)13Gal antibody in baboons by specific alpha-Gal immunoaffinity columns
9. Removal of anti-porcine natural antibodies from human and nonhuman primate plasma in vitro and in vivo by a Galalpha1-3Galbeta1-4betaGlc-X immunoaffinity column
10. Plasma perfusion by apheresis through a Gal immunoaffinity column successfully depletes anti-Gal antibody: Experience with 320 aphereses in baboons
11. Extracorporeal immunoadsorption of alphaGal antibodies
12. Porcine kidney and heart transplantation in baboons undergoing a tolerance induction regimen and antibody adsorption
13. High-dose porcine hematopoietic cell transplantation combined with CD40 ligand blockade in baboons prevents an induced anti-pig humoral response
14. The problem of anti-pig antibodies in pig-to-primate xenografting: Current and novel methods of depletion and/or suppression of production of anti-pig antibodies
15. Disseminated intravascular coagulation in association with the delayed rejection of pig-to-baboon renal xenografts
16. Transfer of swine major histocompatibility complex class II genes into autologous bone marrow cells of baboons for the induction of tolerance across xenogeneic barriers
17. Coagulation and thrombotic disorders associated with pig organ and hematopoietic cell transplantation in nonhuman primates
18. Miniature swine and hDAF pig kidney transplantation in baboons treated with a nonmyeloablative regimen and CD154 blockade
19. Discordant organ xenotransplantation in primates: World experience and current status
20. Experimental renal heterotransplantation. I. In widely divergent species
21. Renal xenograft prolongation by suppression of natural antibody
22. Specific intravenous carbohydrate therapy. A new concept in inhibiting antibody-mediated rejectionexperience with ABO-incompatible cardiac allografting in the baboon
23. Intravenous infusion of Galalphal-3Gal oligosaccharides in baboons delays hyperacute rejection of porcine heart xenografts
24. Intravenous synthetic alphaGal saccharides delay hyperacute rejection following pig-to-baboon heart transplantation
25. Anti-Gal (alpha)1-3Gal antibody response to porcine bone marrow in unmodified baboons and baboons conditioned for tolerance induction
26. Clearance pathways of soluble immune complexes in the pig. Insights into the adaptive nature of antigen clearance in humans
27. A study of in vivo immune complex formation and clearance in man
28. How are immune complexes bound to the primate erythrocyte complement receptor transferred to acceptor phagocytic cells?
29. Glomerular deposition of immune complexes made with IgG2a monoclonal antibodies
30. Peripheral blood progenitor cell mobilization and leukapheresis in pigs
31. Heart transplantation in primates
32. Pharmacologic immunosuppressive therapy and extracorporeal immunoadsorption in the suppression of anti-alphaGal antibody in the baboon
33. Delayed xenograft rejection of pig-to-baboon cardiac transplants after cobra venom factor therapy
34. Porcine hematopoietic cell xenotransplantation in nonhuman primate is complicated by a thrombotic microangiopathy
35. Xenogeneic bone marrow transplantation: I. Cloning, expression, and species specificity of porcine IL-3 and granulocyte-macrophage colony-stimulating factor
36. Xenogeneic bone marrow transplantation: II. Porcine-specific growth factors enhance porcine bone marrow engraftment in an in vitro primate microenvironment
37. Pig hematopoietic cell chimerism in baboons conditioned with a nonmyeloablative regimen and CD154 blockade
38. Human IgM xenoreactive natural antibodies can induce resistance of porcine endothelial cells to complementmediated injury
39. Heterogeneity of preformed human antipig xenogeneic antibodies
40. Monoclonal antiidiotypic antibodies neutralize cytotoxic effects of anti-alphaGal antibodies
41. The reducing end of alpha Gal oligosaccharides contributes to their efficiency in blocking natural antibodies of human and baboon sera
42. Polymorphism within the human anti-pig repertoire
43. Specificity of xenoreactive anti-Gal alpha 1-3Gal IgM for alpha-galactosyl ligands
44. Heterogeneity of human anti-pig natural antibodies cross-reactive with the Gal(alpha1,3)Galactose epitope
45. Polymorphism in the human anti-pig natural antibody repertoire: Implications for antigen-specific immunoadsorption
46. Clearance of mobilized porcine peripheral blood progenitor cells is delayed by depletion of the phagocytic reticuloendothelial system in baboons